Target intelligence / Profile preview

3-mercaptopyruvate sulfurtransferase (MPST)

Target
MPST
Molecular classification
Enzyme, Sulfurtransferase
01

Overview

3-Mercaptopyruvate sulfurtransferase (MPST) is a cytoplasmic enzyme (EC 2.8.1.2) belonging to the rhodanese family of sulfurtransferases, catalyzing the transfer of sulfane sulfur from 3-mercaptopyruvate to acceptors like cyanide or thiols, forming pyruvate and products such as thiocyanate or hydrogen sulfide (H2S). It operates via a double-displacement mechanism involving a catalytic cysteine persulfide intermediate (Cys247 in humans), supported by a Ser-His-Asp triad, and contributes to cysteine degradation, tRNA thiolation, protein urmylation, and cyanide detoxification. MPST is broadly expressed in tissues including liver, kidney, heart, brain, and vasculature, where it generates H2S to modulate nitric oxide signaling and promote vasodilation. Dysregulation links it to oxidative stress resistance, mitochondrial function, fatty acid metabolism, and aging-related changes. In disease, elevated MPST correlates with bladder cancer progression, serving as a potential biomarker, while deficiency causes mercaptolactate-cysteine disulfiduria (Ampola syndrome) with neurological symptoms; it also influences intestinal apoptosis and metabolic disorders. Though not a primary drug target, selective inhibitors targeting its persulfide site have been characterized for H2S modulation research.

Other names
3-mercaptopyruvate:cyanide sulfurtransferasebeta-mercaptopyruvate sulfurtransferasemercaptopyruvate sulfurtransferase
02

Mechanism of action

Inhibition of persulfide formation at catalytic cysteine (Cys247/Cys253); Double displacement via enzyme-bound persulfide intermediate

03

Biological functions

Hydrogen sulfide productionCyanide detoxificationCysteine metabolismThiosulfate biosynthesisProtein persulfidationOxidative stress resistance
04

Disease associations

Bladder cancerMercaptolactate-cysteine disulfiduriaMetabolic diseaseIntestinal epithelial cell apoptosis
05

Safety considerations

Potential disruption of hydrogen sulfide signaling leading to impaired vasodilationAggravation of intestinal apoptosisRole in cyanide detoxification may complicate poisoning treatments
06

Interacting drugs

Selective inhibitors targeting active-site cysteine persulfide (e.g., as described in mechanistic studies)
07

Biomarkers

Increased MPST protein levels and activity in bladder cancer tissues and urothelial cell lines

Beyond the preview

Go deeper on 3-mercaptopyruvate sulfurtransferase (MPST).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on 3-mercaptopyruvate sulfurtransferase (MPST).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call